#Antibodies

Leo Reap

Leo_ReapDO

1. Type III hypersensitivity reactions typically develop ~6 h after exposure to antigen.This is the timeframe we are often seeing patients rapidly decompensate in (2L -> 15L -> intubation), usually

Matt Kaiser

marvel_matt

I’ve been asked a few times recently whether the speedy development of COVID-19 vaccines means anything for cancer treatment – so a thread with a few thoughts - would love

J.D. Vance

JDVance1

Some recent data points of interest: First, German researchers studied a hard hit town. High level takeaway: 14 percent of the town had antibodies, 2 percent had recent infection, .37

Bob Wachter

Bob_Wachter

1/ Covid (@UCSF) Chronicles, Day 70First, @ucsfhospitals, 15 cases, 6 on vents (Fig L). Mild uptick. SF hospitalizations stable-to-down (52 now). Cases plateaued, still averaging ~40/d – no change in

Tony Bitcoin Stark

KingFromEgypt

The Wuhan Virology Institute:Completed in 2013 and partially funded by the U.S guvernment and maintained great relations with Canada's National Microbiology Labratoy. The Lab is very well known for its

Lejoon

lejooon

Since early april I've been wondering if there's not a "black materia" of unexplained immunity to SARS-COV-2 by antibodies alone. The data did not really reconcile with the way cases

Jen🇮🇹🇬🇧❤️

JenBandicoot

Going to be a thread so I don't have to constantly post tweets individually if I ever get into some argument on here, and that I can just post this

Anas Nasir

underthe_scope

Accuracy // #ADayInTheLifeOfABiomedicalScientist1. 8:45am Monday morning. I always tried to get to work a little early, old habits from my previous job. The night team had topped up the reagents

VacciBate

VacciBate

The global efforts on producing an effective vaccine to fight against #COVID19 since the pandemic outbreak are already being translated into results in #clinicaltrials. This week we talked about the

Dena Grayson, MD, PhD

DrDenaGrayson

Good news! 1st peer-reviewed report of a #coronavirus vaccine study shows promising results in 108 participants:No serious safety signals78% in low-dose, 92% in mid-dose, and 100% in high-dose groups developed

Aaron E. Carroll

aaronecarroll

Once in a while, I get to talk about my own back yard. Indiana just conducted the first statewide random sample study to determine the true prevalence of COVID-19. The

Midwestern Hedgie

MidwestHedgie

Another day, another brutally flawed study going around flu bro (bra?) twit. Here's the study: the author's tested residents of Santa Clara Co, CA to see if they had antibodies

RealScientists | Erin

realscientists

It's #epidemiology history time! Up today: vaccination! Smallpox was a deadly disease that can be traced back as far as 3rd century BCE in Egyptian mummies and repeatedly appeared in

Aaron Derfel

Aaron_Derfel

1) Eclipsed by the tragic news of the #COVID19 death of a 19-year-old Repentigny student Friday were two troubling and inter-connected developments. In this thread, I will explain what they

M.E.Valentijn

ME_Valentijn

The Maximale Controle plan of @MinPres, OMT, and @RIVM will fail for 4 reasons:1) If it succeeds, 137K die.2) Natural herd immunity probably won't happen.3) Precise timing & scaling required

Hydroxychloroquine News

niro60487270

Costa Rica is using hydroxychloroquine AND pioneering plasma to treat Covid-19.President Carlos Alvarado Quesada is the most interesting man alive."I don't often crush pandemics. But when I do, I use